Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pancreatic Carcinoma: early-phase trial registry
9 of 19 indexed Pancreatic Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 9 currently recruiting · #902 of 28,707 conditions by registered trial count
Pancreatic Carcinoma: 19 US clinical trials tracked, 9 recruiting.
Pancreatic Carcinoma is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is City of Hope Medical Center, running 3 of these trials.
Enrollment posture brief
Registry condition pancreatic-carcinoma
OPEN 9 | RECR 47% | LATE 1 | EARLY 8 | RANK #902 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Breast Cancer Stage I (47% recruiting · 19 trials)
Pancreatic Carcinoma lists 9 open slots (47% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pancreatic Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pancreatic Carcinoma recruits in line with its size-band peers.
9 of 19 indexed trials (47.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pancreatic Carcinoma research.
City of Hope Medical Center accounts for 3 of 19 trials (15.8%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Pancreatic Carcinoma enrolment sits around 66 participants.
Median target enrolment is 66 among the 19 trials that report a genuine target (sentinel values excluded). 10 of those (52.6%) plan for fewer than 100 participants.
-
Pancreatic Carcinoma research is mostly interventional.
15 interventional and 4 observational studies make up this index (78.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Mayo Clinic
NCT06271291
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
NCT06995898
Pancreatic Cancer Detection Consortium
City of Hope Medical Center
NCT06388967
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Daiichi Sankyo
NCT06172478
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
SWOG Cancer Research Network
NCT06807437
Pilot Study of Pancreatic Cancer Screening
University of California, San Francisco
NCT05058846
A Study of MGC028 in Participants With Advanced Solid Tumors
MacroGenics
NCT06723236
Use Of Indocyanine Green In Pancreas Surgery
OHSU Knight Cancer Institute
NCT06084013
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
University of California, Irvine
NCT05497531
Comparing Two Methods to Follow Patients With Pancreatic Cysts
ECOG-ACRIN Cancer Research Group
NCT04239573
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
NCT04905082
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
NCT06168812
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
NCT04147494
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Julie L. Sutcliffe, Ph.D
NCT03164486
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
Memorial Sloan Kettering Cancer Center
NCT05642962
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
City of Hope Medical Center
NCT02432963
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
Alliance for Clinical Trials in Oncology
NCT06115499
The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer
Ohio State University Comprehensive Cancer Center
NCT04602026
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
Fred Hutchinson Cancer Center
NCT04902144
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pancreatic Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pancreatic Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pancreatic Carcinoma page
19 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Pancreatic Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- City of Hope Medical Center sponsors the most Pancreatic Carcinoma trials on record, review their full trial history before evaluating a specific study. See City of Hope Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pancreatic Carcinoma condition card totals 19 registered trials; most-linked intervention Questionnaire Administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.